Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Tagrisso™ (osimertinib) approved in Japan for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer
-
AstraZeneca reports top-line results from the Brilinta SOCRATES trial in stroke
-
AstraZeneca’s potential medicine for neuromyelitis optica receives FDA Orphan Drug Designation
-
MedImmune receives fast track designation in the US for MEDI8852 for treatment of patients hospitalised with influenza A
-
AstraZeneca enters into agreement with ProStrakan for rights to Moventig in Europe
-
AstraZeneca enters licensing agreement with China Medical System Holdings for hypertension medicine
-
AstraZeneca reports top-line result of tremelimumab monotherapy trial in mesothelioma
-
Acalabrutinib recommended for orphan drug designation in Europe for three indications
-
Zurampic (lesinurad) approved in the European Union for patients with gout
-
Brilique (ticagrelor) approved in EU for extended treatment of patients with history of heart attack
Latest articles and press releases
All of our latest press releases and articles are available to explore
